Improving stem cell therapy for low back pain by enhancing the disc environment
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells
This study is looking at how to better treat low back pain from worn-out discs by using special cells that can help heal them, making it easier for these cells to survive and work effectively in the tough environment of the damaged disc.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11005023 on NIH RePORTER |
What this research studies
This research focuses on addressing low back pain caused by intervertebral disc degeneration, which is a major source of disability in the U.S. The project aims to enhance the effectiveness of mesenchymal stem cells (MSCs) in treating this condition by improving the challenging microenvironment of the degenerate disc. Researchers will develop a biological therapy that delivers essential nutrients, anti-inflammatory agents, and buffering substances to create a more favorable environment for stem cell survival and function. This approach seeks not only to alleviate symptoms but also to restore the natural structure and function of the disc.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from low back pain due to intervertebral disc degeneration.
Not a fit: Patients with low back pain not related to disc degeneration or those with other underlying conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for low back pain that address the root causes rather than just managing symptoms.
How similar studies have performed: Previous research has shown promise in using stem cells for disc regeneration, but this specific approach of neutralizing the degenerate microenvironment is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Smith, Lachlan James — University of Pennsylvania
- Study coordinator: Smith, Lachlan James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.